Thursday, February 9, 2012 Last update: 6:33 PM
The Best of U.S. Company Technology News
Submit Company story ideas to FreshNews.com. See our complete guidelines.
Trade Events
NovaDel Pharma Inc.
News articles for NovaDel Pharma Inc.:
Friday, January 20, 2012
- NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray ProductNovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced the termination of certain license agreements ... read more
Wednesday, January 18, 2012
- NovaDel Continuing to Explore Strategic AlternativesNovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced that, as previously disclosed, it is ... read more
Tuesday, November 1, 2011
- NovaDel Reports Financial Results for Third Quarter 2011NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today reported financial results for the quarter ended ... read more
Monday, August 22, 2011
- NovaDel Signs Exclusive License and Distribution Agreement with Rechon Life Science AB to Manufacture and Commercialize Zolpimist® outside the US and CanadaNovaDel Pharma Inc. (OTC BB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and ... read more